Study of Urelumab in Subjects With Advanced and/or Metastatic Malignant Tumors
Clinical trial NCT02534506 · COMPLETED
Trial details
- NCT number
- NCT02534506
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-06
- Primary completion
- 2016-11-11
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.